A Reexamination of the PPAR-α Activation Mode of Action as a Basis for Assessing Human Cancer Risks of Environmental Contaminants

This publication has 113 references indexed in Scilit:

• Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor α
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2007
• Difficulty of mode of action determination for trichloroethylene: An example of complex interactions of metabolites and other chemical exposures
  Environmental and Molecular Mutagenesis, 2007
• The PPARα-Humanized Mouse: A Model to Investigate Species Differences in Liver Toxicity Mediated by PPARα
  Toxicological Sciences, 2007
• Present concepts and future outlook: Function of peroxisome proliferator‐activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer
  Journal of Cellular Physiology, 2007
• Hepatocyte-restricted constitutive activation of PPAR induces hepatoproliferation but not hepatocarcinogenesis
  Carcinogenesis: Integrative Cancer Research, 2007
• Modes of Action and Species-Specific Effects of Di-(2-ethylhexyl)Phthalate in the Liver
  Critical Reviews in Toxicology, 2006
• Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys
  Carcinogenesis: Integrative Cancer Research, 2004
• The Helsinki Heart Study: an 8.5‐year safety and mortality follow‐up
  Journal of Internal Medicine, 1994
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• Gallbladder Disease as a Side Effect of Drugs Influencing Lipid Metabolism Experience in the Coronary Drug Project
  New England Journal of Medicine, 1977